Try a new search

Format these results:

Searched for:

in-biosketch:true

person:kruppl01

Total Results:

626


The effects of pain, sleep, and fatigue on neuropsychological performance in eosinophilia-myalgia syndrome [Meeting Abstract]

Krupp, LB; Pollina, D; Kaufman, LD; Masur, D
ISI:A1997XV47600040
ISSN: 0364-5134
CID: 2233572

Postinfectious encephalomyelitis multiple sclerosis versus Lyme disease [Meeting Abstract]

Coyle, PK; Krupp, LB
ISI:A1997XV47600314
ISSN: 0364-5134
CID: 2233642

''Voice matching'' can quantify dysarthritic speech in multiple sclerosis [Meeting Abstract]

Pollins, DA; Lawson, TA; Smiroldo, J; Coyle, PK; Krupp, LB
ISI:A1997XV47600311
ISSN: 0364-5134
CID: 2233662

Cognitive-specific deficits in chronic Lyme disease [Meeting Abstract]

Pollina, DA; Squires, NK; Coyle, PK; Krupp, LB
ISI:A1997XV47600035
ISSN: 0364-5134
CID: 2233842

Antigen specificity of cerebrospinal fluid immune complexes in neurologic Lyme disease [Meeting Abstract]

Coyle, PK; Schutzer, SE; Krupp, LB; Belman, AL; Deng, ZD
ISI:A1997XG87100615
ISSN: 0028-3878
CID: 2233862

Postinfectious neurologic syndromes

Chapter by: Krupp, Lauren B
in: Central nervous system infectious diseases and therapy by Roos, Karen L [Eds]
New York : Marcel Dekker, Inc., 1997
pp. 455-480
ISBN: 9780824798116
CID: 2235302

Mechanisms, measurements, and management of fatigue in multiple sclerosis

Chapter by: Krupp, Lauren B
in: Multiple sclerosis : clinical challenges and controversies by Thompson, Alan J; Polman, Chris; Hohlfeld, R [Eds]
London : Martin Dunitz, 1997
pp. 283-291
ISBN: 1853174289
CID: 2235322

Mechanisms and management of fatigue in progressive neurological disorders

Krupp, L B; Pollina, D A
Fatigue in neurologic disorders has been examined in several important studies over the past year. These reports suggest that fatigue is a common and often profoundly debilitating symptom. Assessment and treatment of fatigue requires a multidisciplinary approach.
PMID: 9007405
ISSN: 1350-7540
CID: 1682962

Advances in the treatment of multiple sclerosis [Comment]

Krupp, L B
PMCID:1303860
PMID: 8993213
ISSN: 0093-0415
CID: 1682972

Felbamate-induced headache

Ettinger, A B; Jandorf, L; Berdia, A; Andriola, M R; Krupp, L B; Weisbrot, D M
We prospectively investigated drug-induced headaches (HA) among 60 epileptic patients receiving felbamate (FBM). Twenty patients (33%) experienced HA. HA was pounding in 11 (55%), steady in 9 (45%), moderate or severe in 19 (95%), occurred at least once a week in all patients, and was relieved by nonnarcotic analgesics in 14 (70%). Mean duration on FBM before HA onset was 19 days. HA occurred with higher FBM doses and was relieved in 8 of 13 patients (62%) with FBM dose reduction. FBM was discontinued in most cases because of risks of anemia or hepatitis; not because of HA. Other side effects included insomnia (25%), gastrointestinal symptoms (27%), and agitation or restlessness (23%). HA is a common dose-related complication of FBM, occurs early after initiation of FBM treatment, and is relieved by dose reduction.
PMID: 8617182
ISSN: 0013-9580
CID: 1682982